Related StoriesNew study finds high prevalence of HIV among pregnant refugee women in OntarioSafe, effective douche-centered rectal microbicide can prevent HIV in gay menStudy: Safe areas may play critical part in community-based HIV prevention effortsPROGRESS is a global, multicenter, 96-week open-label study of 200 HIV-infected patients approximately. Both groups, on average, had a similar positive immune response, measured by their increase in CD4+ T-cell counts. The safety and tolerability, including incidences of treatment-emergent moderate-to-serious medication-related adverse events, had been generally comparable between regimens. Kaletra is among the most widely-studied protease inhibitors available, and Abbott believes it is necessary to check out new ways of merging Kaletra with other HIV medicines to explore additional treatment options for individuals, said Scott C.Flavin, Ph.D. CEO of Advanced Existence Sciences. Regulators, market and experts in the field possess long recognized the need for clinical style protocols that will help to provide innovative and essential antimicrobial therapies to the marketplace. Advanced Life Sciences welcomes the opportunity to demonstrate the broad efficacy of our exclusive product candidate and to play a leadership role in advancing the science and medical practice of dealing with pneumonia.